Notes Atherosclerosis
Notes Atherosclerosis
Nicotine
most disease of the arteries
• use o
Age
common )
; fig,ty( contributing tohyperlipidemia
- .
⑨
gender
"
of the arteries
" '
FATTY STREAKS 2 FIBROUS PLAQUES
-
hardening DM (
• Familial predisposition 1 genetics
thickened composed of : speeds atherosclerotic process )
o
small arteries and arterioles -
Obesity
-
"S of
artery .
lipids
-
sedentary lifestyle
ATHEROSCLEROSIS
-
composed of : -
white to white yellow
- .
Elevated C-reactive protein
acclimation of lipids
o -
protrude in various degrees o
Hyper homocysteinemia
)
- :
'
elongated smooth muscles in the arterial lumen
r# lipids " "ed "
jithaegruoemas
"
fgoruonupdiinnctyuediargtenrfianstsgfallo.ge
-
Eimcaicivm -
found predominantly in :
-
large and medium sized arteries -
oxygen
RISK FACTORS I
NICOTINE
C- REACTIVE PROTEIN
HYPERHOMOCYSTEIMIA
Vascular endothelial injury
( ( RP) (ischemic necrosis dlt deficient blood flow )
tobacco of the most sensitive marker of CV inflammation ft ) correlated c- the risk of PAD CAD I
products :
-
one
1
- - .
, ,
T
-
t blood flow to the extremities -
slight TCRPWIS damage risk of in vasculature -
triskcaoggfregaf.it?ntofpfa7eYe7s,ation l
ofemale obesity o
(a) in fibrin DT thrombin formation D
- -
and
-
carbon monoxide ctoxin produced by tobacco) oHPN of blood glucose Irl thrombosis smooth muscle cells
migrate proliferate
readily c- hemoglobin smoking (t ) family hx of CVD Folate
therapy NCEPguidelines : folic acid 1
-
LD combines more o o =
than Oz -
b.
depriving tissues c- 02 -
H) association bet PADI hemostatic supplements of 0.5 -1010mg daily reserved
and elastic fibers to form
matrix of
collagen
.
ATHEROSCLEROSIS
PREVENTION
of
-
of arterial lumen
-
on
-
AHA : reduce amt fat ingested -
-
arises from preexisting vessels that enlarge to
saturated fats
° Obstruction by thrombosis reroute blood flow around a
hemodynamically
vlcholesterol
'
aneurysm significantstenosis or occlusion .
• ulceration -
allows continued perfusion to the tissues but :
•
rupture
often inadequate -17 ischemia
SECONDARY GOAL STATINS HYPERTENSION Cdlttmetabolic demand)
( TXHYPERLIMDEMIAI INDIRECT RESULTS OF
accelerate the rate at Wtc
may ATHEROSCLEROSIS
-
Cholesterol lvlsc
200mg 1dL HMG-CoA reductase inhibitors
- -
malnutrition
- -